Human T lymphocyte genetic modification with naked DNA

Area of Science:

• Immunology
• Molecular Biology
• Biotechnology

Background:

• Genetic modification of T lymphocytes is crucial for cellular immunotherapy.
• Viral vector systems have limitations for clinical applications.
• A novel, non-viral approach is needed for T cell engineering.

Purpose of the Study:

• To develop a plasmid-based electroporation system for genetic modification of primary human T lymphocytes.
• To establish a reliable method for generating genetically modified T cell clones.
• To assess the stability and integration of the modified genetic material.

Main Methods:

• Electroporation of peripheral blood mononuclear cells with linear plasmid DNA.
• Limiting dilution drug selection for isolating G418-resistant T cell clones.
• Fluorescence in situ hybridization (FISH) and Southern blot analysis for integration and copy number determination.
• Chimeric immunoreceptor expression analysis via quantitative PCR and flow cytometry.

Main Results:

• A robust plasmid-based electroporation system was established for generating T lymphocyte clones.
• FISH and Southern blot confirmed single-site chromosomal integration of the plasmid DNA.
• Integrated plasmid was present at a single copy number per cell.
• Chimeric immunoreceptor expression was stable during extensive ex vivo expansion.

Conclusions:

• Plasmid-based electroporation provides a safe and effective non-viral method for T lymphocyte genetic modification.
• This strategy enables the generation of stable, genetically engineered T cell lines for adoptive immunotherapy.
• The approach is currently being evaluated in an FDA-sanctioned clinical trial for lymphoma treatment.